Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +28.68% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +30.37% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Result of General Meeting
- The Biotech Growth Trust PLC - Result of AGM
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 30 June 2024
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 May 2024
- The Biotech Growth Trust PLC - Publication of a circular and notice of general meeting
- The Biotech Growth Trust PLC - Annual Financial Report
- The Biotech Growth Trust Plc - Transaction in Own Shares
More ▼
Key statistics
On Tuesday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,040.00, -2.26% below its 52-week high of 1,064.00, set on Jul 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 32.66m |
---|---|
Market cap | 338.38m GBP |
Total assets | 368.77m GBP |
Total expense ratio | 1.18% |
High | 1,050.00 |
Low | 1,036.00 |
Previous close | 1,040.00 |
Average volume | 129.47k |
---|---|
YTD Change | +16.33% |
Beta | 0.6027 |
Diluted NAV (est) | 1,132.08 |
Diluted NAV (last pub) | 1,129.03 |
Premium/Discount | -8.13% |
Net Gearing | +2.17% |
Data delayed at least 20 minutes, as of Jul 23 2024 16:35 BST.
More ▼